Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cardiovasc Res ; 22(5): 372-4, 1988 May.
Artigo em Inglês | MEDLINE | ID: mdl-3191521

RESUMO

Hydroquinidine concentrations were measured simultaneously in the plasma and in right atrial and ventricular biopsy samples of four dogs in the steady state after eight days of oral sustained release hydroquinidine administration. The right ventricular concentrations were greater than the plasma concentrations in all samples (ratio 5.02(2.2)). In necropsy samples the ventricular concentrations were higher than the atrial concentrations, (ratio 1.54(0.36); p less than 0.01) and than the concentration in the sinus node region (7.72(1.85) ng.g-1 vs 4.21(2.6) ng.g-1). This study shows that intramyocardial pharmacokinetic measurements are possible and may help towards a better understanding of antiarrhythmic agents, particularly those with cumulative myocardial effect.


Assuntos
Miocárdio/metabolismo , Quinidina/análogos & derivados , Animais , Cães , Quinidina/sangue , Quinidina/farmacocinética , Distribuição Tecidual
2.
Pathol Biol (Paris) ; 33(5 Pt 2): 530-2, 1985 Jun.
Artigo em Francês | MEDLINE | ID: mdl-3911149

RESUMO

20, 30 and 90 minutes after a single intravenous injection of 2 g of cefotiam prostatic tissue and serum samples were taken from 12 patients who underwent transabdominal prostatectomy for prostatic adenoma. Cefotiam was assayed by HPLC. Mean serum and prostatic concentrations were respectively 157 +/- 39 mg/ml and 42 +/- 23 mg/g at 20 mn, 77 +/- 52 mg/ml and 54 +/- 2 mg/g at 30 mn, 36 +/- 21 mg/ml and 16 +/- 18 mg/g at 90 mn. Elimination half-life of cefotiam was 1 h 39 mn for serum and 1 h 10 mn for prostatic tissue. These findings confirm the satisfactory diffusion of cefotiam within prostatic tissue, although saturation occurs after 30 mn. Treatment of prostatitis by cefotiam can be expected to give excellent results.


Assuntos
Cefotaxima/análogos & derivados , Próstata/metabolismo , Adenoma/cirurgia , Idoso , Infecções Bacterianas/tratamento farmacológico , Cefotaxima/sangue , Cefotaxima/metabolismo , Cefotaxima/uso terapêutico , Cefotiam , Cromatografia Líquida de Alta Pressão , Meia-Vida , Humanos , Cinética , Masculino , Prostatectomia , Neoplasias da Próstata/cirurgia , Prostatite/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...